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Analysis of TRIM5α and APOBEC3G genes suggests that
these two restriction factors underwent strong positive
selection throughout primate evolution. This pressure was
possibly imposed by ancient exogenous retroviruses, of
which endogenous retroviruses are remnants. Our study
aims to assess in vitro the activity of these factors against
ancient retroviruses by reconstructing their ancestral gag
sequences, as well as the ancestral TRIM5α and
APOBEC3G for primates.
Based on evolutionary genomics approach, we recon-
structed ancestors of the two largest families of human
endogenous retroviruses (HERV), namely HERV-K and
HERV-H, as well as primate ancestral TRIM5α and
APOBEC3G variants. The oldest TRIM5α sequence was
the catarhinne TRIM5α, common ancestor of Old World
monkeys and hominoids, dated from 25 million years ago
(mya). From the oldest, to the youngest, ancestral
TRIM5α variants showed less restriction of HIV-1 in vitro
[1]. Likewise three ancestral APOBEC3Gs sequences com-
mon to hominoids (18 mya), Old World monkeys, and
catarhinnes (25 mya) were reconstructed. All ancestral
APOBEC3G variants inhibited efficiently HIV-1Δvif in
vitro, compared to modern APOBEC3Gs. The ability of Vif
proteins (HIV-1, HIV-2, SIVmac and SIVagm) to counter-
act their activity tallied with the residue 128 on ancestral
APOBEC3Gs. Moreover we are attempting to reconstruct
older ancestral sequences of both restriction factors by
using prosimian orthologue sequences. An infectious one-
million-years-old HERV-KCON  previously reconstituted
was shown to be resistant to modern TRIM5α and
APOBEC3G [2]. Our ancestral TRIM5α and APOBEC3G
variants were inactive against HERV-KCON. Besides we
reconstructed chimeric HERV-K bearing ancestral capsids
(up to 7 mya) that resulted in infectious viruses resistant
to modern and ancestral TRIM5α. Likewise HERV-K
viruses bearing ancestral nucleocapsids will be tested for
ancestral and modern APOBEC3G restriction.
In silico reconstruction and structural modeling of ances-
tral HERV-H capsids resulted in structures homologous to
that of the gammaretrovirus MLV. Thus we are attempting
to construct chimeric MLV virus bearing HERV-H ances-
tral capsids. These chimeric ancestral HERVs will be tested
for infectivity and restriction by ancestral TRIM5α. Simi-
larly chimeric MLV viruses bearing ancestral HERV-H
nucleocapsids will be reconstructed and tested for
APOBEC3G restriction.
References
1. Goldschmidt V, Ciuffi A, Ortiz M, Brawand D, Muñoz M, Kaessmann
H, Telenti A: Antiretroviral activity of ancestral TRIM5alpha.
J Virol 2008, 82(5):2089-96.
2. Lee YN, Bieniasz PD: Reconstitution of an infectious human
endogenous retrovirus.  PLoS Pathog 2007, 3(1):e10.
from Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts
Montpellier, France. 21-23 September 2009
Published: 24 September 2009
Retrovirology 2009, 6(Suppl 2):P75 doi:10.1186/1742-4690-6-S2-P75
<supplement> <title> <p>Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts</p> </title> <note>Meeting abstracts - A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S2-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1742-4690-6-S2-info.pdf</url> </supplement>
This abstract is available from: http://www.retrovirology.com/content/6/S2/P75
© 2009 Rahm et al; licensee BioMed Central Ltd. 